Total miss guided to say the least. NWBO is one of the first pioneers in the field of GBM brain cancer as many here know this fact. The truth of the matter is that NWBO is worth more than current face value and that is also a fact. As for BP deal, yes that is questionable issue for NWBO. As a shareholder I would hope that NWBO would not sell out to any BP offer for pennies, IMPO. Fortunately, NWBO has no accusations of accounting irregularities with the SEC. The key point is that NWBO has in fact made significant progress since it started, and certainly over the last 8+ years and counting. The good news is that JAMA agrees with NWBO, and many doctors, scientist, and professionals are in agreement with NWBO. The partnership between NWBO and Dr. Linda Liau and her team are another major factor for success as NWBO moves forward. As a scientist who has invest both time, and resource investments in NWBO, I continue to pray for good news and for both current and future nGBM and rGBM brain cancer patients all over the world. Investing is one thing, saving and extending the lives of cancer patients is certainly priceless. All the best!